Clinical Trials Browser

Phase 2 × Kaposiform Hemangioendothelioma × Clear all

NCT05324384 2024-01-24

Different Doses of Sirolimus for the Maintenance Treatment of Kaposiform Hemangioendothelioma

Phase 2 Unknown

Kaposiform Hemangioendothelioma, Hemangioendothelioma

NCT02110069 2023-09-21

A Study to Compare Vincristine to Sirolimus for Treatment of High Risk Vascular Tumors

Phase 2 Terminated

4 enrolled 8 charts

Tufted angioma, Kaposiform Hemangioendothelioma, Hemangioendothelioma, Vascular Malformations, Kasabach-Merritt Syndrome

NCT03188068 2022-04-21

Sirolimus Versus Sirolimus Plus Prednisolone for Kaposiform Hemangioendothelioma

Phase 2 Completed

Kaposiform Hemangioendothelioma, Kasabach-Merritt Syndrome